Law Updates
Latest notifications, circulars, orders and compliance changes.
Showing 6 of 658 result(s)
Subject
BIS Standards Amendments 2026: 19 Indian Standards Updated in OctoberSummary: The Bureau of Indian Standards (BIS) has notified amendments to 19 Indian Standards covering cosmetics, sanitary products, medical textiles, plastics, agricultural equipment, petroleum testing and other products. The notification, dated 27 October 2026 and published in the Gazette of India dated 29 October 2026, establishes amendments with effect from 26 October 2026. The standards without these amendments will remain in force until 25 April 2027. BIS Standards Amendments 2026 will be important for the manufacturers, testing labs, suppliers, and organizations that have obtained the related BIS
Subject
NGO Merger Rules 2026- Rule 189A, Form 112A and Income-Tax ComplianceSummary: The Central Board of Direct Taxes (CBDT) has introduced new conditions for mergers of registered non-profit organisations under the Income-tax (Eighth Amendment) Rules, 2026. Issued on 30 October 2026, the notification adds Rule 189A and Form No. 112A to the Income-tax Rules, 2026. The new NGO merger rules 2026 explain when registered non-profit organisations with similar objectives can qualify for the prescribed merger treatment. They also address outstanding tax demands, transfer of liabilities, audit requirements and electronic reporting. For charitable trusts, NGOs and other eligible non-p
Subject
NDPS Notifications October 2026- New Drug Classifications and Quantity LimitsSummary: Three notifications have been made by the Ministry of Finance, Department of Revenue, under the NDPS Act, 1985, on 28 October 2026. The government has notified two such substances as manufactured drugs, while MDMB-FUBINACA has been added to the category of psychotropic substances along with quantity limits. The changes are relevant to businesses, research organisations and laboratories that handle these substances. They also establish quantity thresholds used when applying certain provisions of the NDPS Act. The notifications do not introduce a general registration requirement for every pharma
Schedule a Call Back
Subject
CAQM Mandates Electric Three-Wheeler Registration in Delhi-NCR from 2027Summary: New registrations for L5 three-wheelers using CNG and other non-electric fuels would be subject to phase-wise bans in Delhi-NCR as per CAQM Direction No. 100 dated 15 May 2026. From 1 January 2027, only electric L5 three-wheelers can be registered in Delhi. This provision shall apply to five districts of NCR where vehicle density is high from 1 January 2028 and to the rest of NCR districts from 1 January 2029. The rules cover passenger and goods-carrying L5 three-wheelers. For manufacturers, dealers and fleet operators, the change makes future vehicle purchases, inventory planning and EV infra
Subject
Textile PLI Scheme 2026 Amendment - Round 4 Eligibility, Incentives and Application DeadlineSummary: The Ministry of Textiles has made important changes to the Production Linked Incentive (PLI) Scheme for textiles through a notification issued on 28 October 2026. The most significant amendment for the Round 4 applicants is the decrease in the minimum turnover criteria of Part II from 200 crore rupees to 100 crore rupees. The government has also extended the scheme period, introduced provisions for existing participants to move to Round 4 and announced a new application window from 1 November to 31 December 2026. These changes matter to businesses manufacturing man-made fibre (MMF) apparel, MM
Subject
Drug Import Shelf-Life Rules 2026: What Has Changed Under Rule 31?Summary: A medicine may still be within its expiry date but fail to meet India's import requirements. What matters is how much shelf life remains when the drug is imported. The Ministry of Health and Family Welfare has revised the drug import shelf-life rules in India through notification G.S.R. 951(E), introducing the Drugs (Thirteenth Amendment) Rules, 2026. Under the amended Rule 31, imported drugs must generally have at least one year of remaining shelf life. Biological drugs and radiopharmaceuticals have a separate provision under which 60% of their labelled shelf life may be allowed. The chan
Subscribe to Us
Find different law updates directly in your inbox. Subscribe now.
